NasdaqGS:MEDPLife Sciences
Medpace (MEDP) Stock Faces Margin Compression That Tests Bullish Growth Narratives
Medpace Holdings (MEDP) opened Q2 2026 with total revenue of US$707.3 million and basic EPS of US$4.31, while trailing twelve month figures show revenue of US$2.8 billion and EPS of US$17.39 alongside 17.5% earnings growth and 21.2% annual earnings compounding over five years. The company has seen revenue move from US$2.2 billion and EPS of US$13.83 on a trailing basis in Q2 2025 to the latest trailing tallies, with earnings growth of 8.5% and revenue growth of 6.7% flagged in forecasts,...